Role of serum fibroblast growth factor-23 and Klotho level in COVID-19 infection-related mortality: a prospective study
The Journal of Infection in Developing Countries · 2024
DOI: 10.3855/jidc.20272 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2024. Verfasst von Davut Akin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Pamukkale University School of Medicine, Denizli,Turkey. Hauptthemen laut MEDLINE: Klotho Proteins, COVID-19, Fibroblast Growth Factors, Glucuronidase. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
This study investigated the role of fibroblast growth factor 23 (FGF23)/Klotho in the mortality of patients hospitalized with coronavirus disease 2019 (COVID-19), excluding those with chronic kidney disease (CKD). Methodology: A prospective cross-sectional study was conducted from April 2021 to May 2022. Patients who tested positive for COVID-19 via polymerase chain reaction and were hospitalized, were classified into two groups (survivors and non-survivors) at the end of their hospital follow-up. Demographic data, clinical status, and prognosis were analyzed.
Results
A total of 66 patients (age 58.8 ± 17.0 years, 60.6% male) were included. The mean age of non-survivors (67.2 ± 1 years) was significantly higher than the survivors (49.2 ± 1 years; p < 0.0001). FGF23 was significantly elevated in non-survivors (301 ± 20 pg/mL), compared to survivors (160 ± 36 pg/mL; p < 0.0001). Factors with significant differences (p < 0.001) between the two groups were investigated as independent mortality predictors using logistic regression analysis. FGF23 (p = 0.01), age (p = 0.045), and oxygen saturation at admission (p = 0.02) were independent predictors of mortality. High serum FGF23 levels were associated with COVID-19-related mortality; Klotho levels were lower (p = 0.028). Vitamin D was not significantly different between the groups.
Conclusion
Elevated serum FGF23 and parathyroid hormone (PTH), and lower Klotho levels, were associated with COVID-19-related mortality in patients without CKD. There was no association with serum vitamin D levels. Further studies are required to establish the relationship between mortality and FGF23/Klotho, PTH, and vitamin D levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Pamukkale University School of Medicine, Denizli,Turkey.
- Department of İntensive care, Nazilli State Hospital, Aydin,Turkey.
- Department of Family Medicine, Pamukkale University School of Medicine, Denizli,Turkey.
- Department of Physiology, Pamukkale University School of Medicine, Denizli,Turkey.
- Camlica Hospital Department of Nephrology, Medipol University, Istanbul,Turkey.
- Department of Gastroenterology, Pamukkale University School of Medicine, Denizli,Turkey.
Zitieren
APA
Akin, D., Aydogan, B. B., Emre, N., Gundogdu, G., Ozmen, S., Erkek, O. K., & Alpua, M. (2024). Role of serum fibroblast growth factor-23 and Klotho level in COVID-19 infection-related mortality: a prospective study. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.20272
Vancouver
Akin D, Aydogan BB, Emre N, Gundogdu G, Ozmen S, Erkek OK, et al. Role of serum fibroblast growth factor-23 and Klotho level in COVID-19 infection-related mortality: a prospective study. The Journal of Infection in Developing Countries. 2024. doi:10.3855/jidc.20272
BibTeX
@article{Akin2024,
author = {Akin, Davut and Aydogan, Burcu B and Emre, Nilufer and Gundogdu, Gulsah and Ozmen, Sehmus and Erkek, Ozgen K and Alpua, Mehmet},
title = {Role of serum fibroblast growth factor-23 and Klotho level in COVID-19 infection-related mortality: a prospective study},
journal = {The Journal of Infection in Developing Countries},
year = {2024},
doi = {10.3855/jidc.20272}
}
EUVIMED